Organization Overview
Historical Acquisition Tree
Alternative names
odevixibat (BYLVAY) (2021 NDA)
Key: Albireo (1) Acquired (3)
Alagille Syndrome (Phase 3)
Biliary Atresia (Phase 3)
Cholestasis (Phase 3)
Cholestasis, Intrahepatic (Phase 3)
Constipation (Phase 2)
Dyslipidemias (Phase 2)
Fibrosis (Phase 2)
Liver Cirrhosis (Phase 2)
Liver Cirrhosis, Biliary (Phase 2)
Liver Diseases (Phase 1)
Malabsorption Syndromes (Phase 2)
Non-alcoholic Fatty Liver Disease (Phase 2)
Pruritus (Phase 2)
Syndrome (Phase 3)